Common Sense for Drug Policy - Link to home page


Thursday, October 19, 2017
Search using CSDP's own search tool or use
Google

WWW Common Sense


Home page

About CSDP

PSA Campaign


Check out these other CSDP news pages:
Afghanistan
AIDS
Anti-Drug Media Campaign
Asia and the US Drug War
Bolivia
Bush's Cabinet
Burma
Canada
Chronic Pain Management
Colombia
Communities Against the Drug War
Conferences & Events
Corruption
DARE Admits Failure
Drug Control Alternatives
Ecstasy
Families Targeted by Drug War
Federal Drug Control Strategy
Hemp News
Heroin & Heroin Addiction Treatment
Higher Education Act (HEA) Reform
Initiatives
International Reform
Laos
Mandatory Minimums
Marijuana
Medical Marijuana
Methamphetamines
Mexico
Narco-Funded Terrorism
New Mexico
Nixon
New York
ONDCP
OxyContin
Pain Management
Peru
Police Shootings & Botched Raids
Prop 36
Racial Profiling
Recommended Reading
Research News
South America
Thailand
Treatment Alternatives to Incarceration
Tulia
United Kingdom Moves Toward Reform
United Nations: News and Reports


Drug War Facts

Research Archive

Coalition for Medical Marijuana

Managing Chronic Pain

Drug War Distortions

Safety First

Get Active!

Drug Truth Network

Links

Drug Strategy

Drugs and Terror

Recommended Reading

Site Map



link to 
Drug War Facts - page opens in new window
Addict 
in the Family

Online Drug Library

Research Resources

Contact Common Sense



Click here for more about Medical Marijuana.

CSDP Blog



One Step Forward, Two Steps Back for New Jersey Medical Marijuana Bill

New Jersey's Compassionate Use Medical Marijuana Act (A804/S119) passed through the state's Assembly health committee, but if the full Assembly ultimately votes in favor of the measure, New Jersey will be home to the most conservative medical marijuana laws in the country.

As Ken Wolski writes in his June 23 article ("Marijuana Bill Restrictions"), "No state has a lower plant limit or possession amount than New Jersey's bill would alllow. The committee's substitutions to the bill are overly restrictive and they possibly render the bill unworkable." In addition, the version of the bill on which the full Assembly will vote "remove[s] the provision for qualified patients to grow their own supply of marijuana; place[s] severe and unnecessary restrictions on physician recommendations; and den[ies] access to the largest population of patients, those suffering from chronic pain." As Wolski notes, chronic pain patients (excluding those using marijuana to treat pain associated with HIV/AIDS and cancer, to whom the bill does allow access to the drug) make up almost "half of all current physician recommendations for marijuana therapy," and "[s]ome of the most rigorous studies establishing the safety and efficacy of medical marijuana in pain management" have proved cannabis' "worth as a pain management tool."

The future of New Jersey's medical marijuana program is not, however, as bleak as it may seem. In his article, Wolski notes that the Coalition for Medical Marijuana-New Jersey "recommends that the Senate version of [the bill], which does not contain the Assembly health committee's substitutions, pass into law without delay. This will ensure that patients who are suffering from debilitating medical conditions can quickly begin to relieve their suffering and no longer need fear arrest and imprisonment for following the advice of their physicians."

Back to top